Особенности фармакодинамики и фармакокинетики противоотечного средства эсцина лизината

Закрыть метаданные

Рекомендуем статьи по данной теме:

Эффективность местной терапии у пациентов с субъективными симптомами хронических заболеваний вен. Флебология. 2024;(4):302-307

Флеболимфедема: современные представления и возможности коррекции. Флебология. 2024;(4):339-350

Резолюция Совета экспертов по лечению дискогенной пояснично-крестцовой радикулопатии «Новые подходы к терапии боли в спине, использование L-лизина эсцината». Российский журнал боли. 2025;(1):84-90

Отек является типовым патологическим процессом, сопровождающим широкий ряд заболеваний и состояний. Коррекция отека необходима для нормализации перфузии и трофики ткани, предупреждения вторичных нарушений и осложнений, облегчения боли и улучшения общего состояния пациента. Настоящий обзор посвящен механизмам действия тритерпенового сапонина эсцина и его эффективности при отеках различного генеза и с разной локализацией. Эсцин ингибирует гидролитические ферменты, предупреждает индукцию молекул клеточной адгезии, снижает активность провоспалительных сигнальных путей, поддерживает целостность межклеточных контактов, а также защищает клетки эндотелия от повреждения и нарушения функции. Экспериментальными и клиническими исследованиями установлено наличие у эсцина дополнительного противовоспалительного, анальгетического и антиоксидантного эффекта.

Ключевые слова:

эсцин

эсцина лизинат

отек

противоотечные средства

эндотелиопротекторы

Авторы:

Приходько В.А.

ФГБОУ ВО «Санкт-Петербургский государственный химико-фармацевтический университет» Минздрава России

ORCID: 0000-0002-4690-1811

Оковитый С.В.

ФГБОУ ВО «Санкт-Петербургский государственный химико-фармацевтический университет» Минздрава России

ORCID: 0000-0003-4294-5531

Дата поступления:

08.05.2025

Дата принятия в печать:

09.06.2025

Список литературы:

Stokum JA, Gerzanich V, Sheth KN, Kimberly WT, Simard JM. Emerging Pharmacological Treatments for Cerebral Edema: Evidence from Clinical Studies. Annual Review of Pharmacology and Toxicology. 2020;60:291-309. https://doi.org/10.1146/annurev-pharmtox-010919-023429
Keeley V. Pharmacological treatment for chronic oedema. British Journal of Community Nursing. 2008;13(4):S4-S10. https://doi.org/10.12968/bjcn.2008.13.Sup2.29394
van den Bekerom MP, Struijs PA, Blankevoort L, Welling L, van Dijk CN, Kerkhoffs GM. What is the evidence for rest, ice, compression, and elevation therapy in the treatment of ankle sprains in adults?. Journal of Athletic Training. 2012;47(4):435-443. https://doi.org/10.4085/1062-6050-47.4.14
Geisler R, Dargel C, Hellweg T. The Biosurfactant β-Aescin: A Review on the Physico-Chemical Properties and Its Interaction with Lipid Model Membranes and Langmuir Monolayers. Molecules. 2019;25(1):117. https://doi.org/10.3390/molecules25010117
Государственный реестр лекарственных средств Российской Федерации. Ссылка активна на 25.05.25. https://grls.rosminzdrav.ru/GRLS.aspx
Gallelli L. Escin: a review of its anti-edematous, anti-inflammatory, and venotonic properties. Drug Design, Development and Therapy. 2019; 13:3425-3437. https://doi.org/10.2147/DDDT.S207720
Facino RM, Carini M, Stefani R, Aldini G, Saibene L. Anti-elastase and anti-hyaluronidase activities of saponins and sapogenins from Hedera helix, Aesculus hippocastanum, and Ruscus aculeatus: factors contributing to their efficacy in the treatment of venous insufficiency. Archiv der Pharmazie (Weinheim). 1995;328(10):720-724. https://doi.org/10.1002/ardp.19953281006
Marhuenda E, Alarcón de la Lastra C, Martín MJ. Antisecretory and gastroprotective effects of aescine in rats. General Pharmacology. 1994;25(6): 1213-1219. https://doi.org/10.1016/0306-3623(94)90140-6
Marcianò G, Vocca C, Dıraçoğlu D, Sevgin RÖ, Gallelli L. Escin’s Action on Bradykinin Pathway: Advantageous Clinical Properties for an Unknown Mechanism?. Antioxidants (Basel). 2024;13(9):1130. https://doi.org/10.3390/antiox13091130
Montopoli M, Froldi G, Comelli MC, Prosdocimi M, Caparrotta L. Aescin protection of human vascular endothelial cells exposed to cobalt chloride mimicked hypoxia and inflammatory stimuli. Planta Medica. 2007;73(3): 285-288. https://doi.org/10.1055/s-2007-967118
Zhang K, Jiang Z, Ning X, Yu X, Xu J, Buzzacott P, Xu W. Endothelia-Targeting Protection by Escin in Decompression Sickness Rats. Scientific Reports. 2017;7:41288. https://doi.org/10.1038/srep41288
Domanski D, Zegrocka-Stendel O, Perzanowska A, Dutkiewicz M, Kowalewska M, Grabowska I, Maciejko D, Fogtman A, Dadlez M, Koziak K. Molecular Mechanism for Cellular Response to β-Escin and Its Therapeutic Implications. PLoS One. 2016;11(10):e0164365. https://doi.org/10.1371/journal.pone.0164365
Arnould T, Janssens D, Michiels C, Remacle J. Effect of aescine on hypoxia-induced activation of human endothelial cells. European Journal of Pharmacology. 1996;315(2):227-233. https://doi.org/10.1016/s0014-2999(96)00645-0
Ji DB, Xu B, Liu JT, Ran FX, Cui JR. β-Escin sodium inhibits inducible nitric oxide synthase expression via downregulation of the JAK/STAT pathway in A549 cells. Molecular Carcinogenesis. 2011;50(12):945-960. https://doi.org/10.1002/mc.20762
Chen C, Wang S, Chen J, Liu X, Zhang M, Wang X, Xu W, Zhang Y, Li H, Pan X, Si M. Escin suppresses HMGB1-induced overexpression of aquaporin-1 and increased permeability in endothelial cells. FEBS Open Bio. 2019;9(5):891-900. https://doi.org/10.1002/2211-5463.12622
Wang B, Yang R, Ju Q, Liu S, Zhang Y, Ma Y. Clinical effects of joint application of β-sodium aescinate and mannitol in treating early swelling after upper limb trauma surgery. Experimental and Therapeutic Medicine. 2016;12(5):3320-3322. https://doi.org/10.3892/etm.2016.3743
Paneerselvam C, Ganapasam S. β-Escin alleviates cobalt chloride-induced hypoxia-mediated apoptotic resistance and invasion via ROS-dependent HIF-1α/TGF-β/MMPs in A549 cells. Toxicology Research (Cambridge). 2020;9(3):191-201. https://doi.org/10.1093/toxres/tfaa019
Vašková J, Fejerčáková A, Mojžišová G, Vaško L, Patlevič P. Antioxidant potential of Aesculus hippocastanum extract and escin against reactive oxygen and nitrogen species. European Review for Medical and Pharmacological Sciences. 2015;19(5):879-886. Accessed May 25, 2025. https://pubmed.ncbi.nlm.nih.gov/25807442/
Li M, Liu X, Zhou X, Meng R, Ji X. Escin Rescues Blood-brain Barrier and Inhibits NLRP3 Inflammasome-mediated Pyroptosis in Rats with Superior Sagital Sinus Thrombosis. International Journal of Medical Sciences. 2025;22(7):1602-1611. https://doi.org/10.7150/ijms.102624
Li M, Lu C, Zhang L, Zhang J, Du Y, Duan S, Wang T, Fu F. Oral Administration of Escin Inhibits Acute Inflammation and Reduces Intestinal Mucosal Injury in Animal Models. Evidence-Based Complementary and Alternative Medicine. 2015;2015:503617. https://doi.org/10.1155/2015/503617
Li M, Wang S, Zhang C, Chi C, Liu R, Wang T, Fu F. Escin alleviates stress-induced intestinal dysfunction to protect brain injury by regulating the gut-brain axis in ischemic stroke rats. International Immunopharmacology. 2023;115:109659. https://doi.org/10.1016/j.intimp.2022.109659
Sun X, Liu Z, Zhou L, Ma R, Zhang X, Wang T, Fu F, Wang Y. Escin avoids hemorrhagic transformation in ischemic stroke by protecting BBB through the AMPK/Cav-1/MMP-9 pathway. Phytomedicine. 2023;120:155071. https://doi.org/10.1016/j.phymed.2023.155071
Raffetto JD, Khalil RA. Ca(2+)-dependent contraction by the saponoside escin in rat vena cava: implications in venotonic treatment of varicose veins. Journal of Vascular Surgery. 2011;54(2):489-496. https://doi.org/10.1016/j.jvs.2011.01.043
Carrasco OF, Vidrio H. Endothelium protectant and contractile effects of the antivaricose principle escin in rat aorta. Vascular Pharmacology. 2007; 47(1):68-73. https://doi.org/10.1016/j.vph.2007.04.003
Gallelli L, Cione E, Wang T, Zhang L. Glucocorticoid-Like Activity of Escin: A New Mechanism for an Old Drug. Drug Design, Development and Therapy. 2021;15:699-704. https://doi.org/10.2147/DDDT.S297501
Jiang N, Xin W, Wang T, Zhang L, Fan H, Du Y, Li C, Fu F. Protective effect of aescin from the seeds of Aesculus hippocastanum on liver injury induced by endotoxin in mice. Phytomedicine. 2011;18(14):1276-1284. https://doi.org/10.1016/j.phymed.2011.06.011
Wang H, Zhang L, Jiang N, Wang Z, Chong Y, Fu F. Anti-inflammatory effects of escin are correlated with the glucocorticoid receptor/NF-κB signaling pathway, but not the COX/PGF2α signaling pathway. Experimental and Therapeutic Medicine. 2013;6(2):419-422. https://doi.org/10.3892/etm.2013.1128
Zhao SQ, Xu SQ, Cheng J, Cao XL, Zhang Y, Zhou WP, Huang YJ, Wang J, Hu XM. Anti-inflammatory effect of external use of escin on cutaneous inflammation: possible involvement of glucocorticoids receptor. Chinese Journal of Natural Medicines. 2018;16(2):105-112. https://doi.org/10.1016/S1875-5364(18)30036-0
Xin W, Zhang L, Sun F, Jiang N, Fan H, Wang T, Li Z, He J, Fu F. Escin exerts synergistic anti-inflammatory effects with low doses of glucocorticoids in vivo and in vitro. Phytomedicine. 2011;18(4):272-277. https://doi.org/10.1016/j.phymed.2010.08.013
Park AY, Lee JO, Jang YN, Kim SY, Heo JH, Kim YJ, Lee JM, Yoon DW, Kim BJ, Seok J. Ameliorative Effects of Escin on Inflammation via Glucocorticoid Receptor (GR) in Atopic Dermatitis (AD) Mouse Model. Journal of Microbiology and Biotechnology. 2025;35:e2410025. https://doi.org/10.4014/jmb.2410.10025
Annoni F, Mauri A, Marincola F, Resele LF. Venotonic activity of escin on the human saphenous vein. Arzneimittelforschung. 1979;29(4):672-675. Accessed May 25, 2025. https://pubmed.ncbi.nlm.nih.gov/582766
Wang T, Fu F, Zhang L, Han B, Zhu M, Zhang X. Effects of escin on acute inflammation and the immune system in mice. Pharmacological Reports. 2009;61(4):697-704. https://doi.org/10.1016/s1734-1140(09)70122-7
Zhang L, Wang H, Fan H, Wang T, Jiang N, Yu P, Fu F. The potent anti-inflammatory agent escin does not increase corticosterone secretion and immune cell apoptosis in mice. Fitoterapia. 2011;82(6):861-867. https://doi.org/10.1016/j.fitote.2011.04.004
Elshal M, Hazem SH. Escin suppresses immune cell infiltration and selectively modulates Nrf2/HO-1, TNF-α/JNK, and IL-22/STAT3 signaling pathways in concanavalin A-induced autoimmune hepatitis in mice. Inflammopharmacology. 2022;30(6):2317-2329. https://doi.org/10.1007/s10787-022-01058-z
Xu F, Jiang Y, Wang X, Shen L, Yan Y, Guo D, Wang C. Sodium aescinate inhibits microglia activation through NF-κB pathway and exerts neuroprotective effect. Frontiers in Pharmacology. 2023;14:1086429. https://doi.org/10.3389/fphar.2023.1086429
Avci G, Küçükkurt I, Küpeli Akkol E, Yeşilada E. Effects of escin mixture from the seeds of Aesculus hippocastanum on obesity in mice fed a high fat diet. Pharmaceutical Biology. 2010;48(3):247-252. https://doi.org/10.3109/13880200903085466
Sharipov A, Tursunov K, Fazliev S, Azimova B, Razzokov J. Hypoglycemic and Anti-Inflammatory Effects of Triterpene Glycoside Fractions from Aeculus hippocastanum Seeds. Molecules. 2021;26(13):3784. https://doi.org/10.3390/molecules26133784
Vedantam D, Poman DS, Motwani L, Asif N, Patel A, Anne KK. Stress-Induced Hyperglycemia: Consequences and Management. Cureus. 2022; 14(7):e26714. https://doi.org/10.7759/cureus.26714
Wang Y, Han X, Wan X, Niu F, Zhou C. β-Escin: An Updated Review of Its Analysis, Pharmacology, Pharmacokinetics, and Toxicity. The American Journal of Chinese Medicine. 2023;51(8):2095-2120. https://doi.org/10.1142/S0192415X23500908
Wu XJ, Zhang ML, Cui XY, Paul Fawcett J, Gu JK. Comparative pharmacokinetics and the bioavailability of escin Ib and isoescin Ib following the administration of escin, pure escin Ib and isoescin Ib in rats. Journal of Ethnopharmacology. 2014;151(2):839-845. https://doi.org/10.1016/j.jep.2013.11.039
Hu JN, Zhu XM, Han LK, Saito M, Sun YS, Yoshikawa M, Kimura Y, Zheng YN. Anti-obesity effects of escins extracted from the seeds of Aesculus turbinata BLUME (Hippocastanaceae). Chemical and Pharmaceutical Bulletin (Tokyo). 2008;56(1):12-16. https://doi.org/10.1248/cpb.56.12
Huang S, Wang X, Liu M, Lin Z, Gu W, Zhao H, Zhang Y, Ding B, Liu J, Wu X, Fan W, Chen J. Modification of sodium aescinate into a safer, more stable and effective water-soluble drug by liposome-encapsulation: an in vitro and in vivo study. Drug Delivery. 2022;29(1):1132-1141. https://doi.org/10.1080/10717544.2022.2058114
Чуканова Е.И., Чуканова А.С., Мамаева Х.И. Хроническая церебральная венозная недостаточность. Этиология, клиника, лечение. Поликлиника. 2018;(5):23-27.

Закрыть метаданные